Differential Impact of Polymyxin B Hemadsorption on Long‐Term Mortality in Septic Shock: A Retrospective Analysis of Intra‐Abdominal Versus Extra‐Abdominal Infections
Artificial Organs · 2025
DOI: 10.1111/aor.70023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Artificial Organs, 2025. Verfasst von Tomoki Tanaka und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical and Intensive Care Medicine, Shiga University of Medical Science, Otsu, Japan. Hauptthemen laut MEDLINE: Polymyxin B, Shock, Septic, Hemoperfusion, Intraabdominal Infections. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Sepsis
Abstract (Originalsprache)
Background
The long‐term benefit of polymyxin B hemadsorption (PMX‐HA) in septic shock patients remains unclear and may depend on the site of infection. We evaluated the association between PMX‐HA use and 1‐year mortality in patients with intra‐abdominal infection (IAI) and extra‐abdominal infection (EAI).
Methods
We retrospectively analyzed adult patients with septic shock (Sepsis‐3) admitted to an ICU between January 2017 and July 2023. Patients were categorized as IAI or EAI and further stratified by PMX‐HA use. One‐year mortality was assessed using Kaplan–Meier analysis, multivariable Cox regression (adjusted for age, sex, and SOFA score), and inverse probability of treatment weighting (IPTW), balancing age, sex, SOFA, CRRT use, and with or without surgical and/or radiological interventions.
Results
Among 182 patients (98 IAI, 84 EAI), PMX‐HA was administered to 71 IAI and 32 EAI patients. In the IAI group, PMX‐HA was associated with significantly lower 1‐year mortality (32.3% vs. 59.2%, p = 0.005), supported by Cox regression (adjusted HR: 0.485; 95% CI: 0.252–0.935; p = 0.031) and IPTW (weighted HR: 0.415; 95% CI: 0.215–0.787; p = 0.007). In contrast, in the EAI group, 1‐year mortality was similar between the non‐PMX and PMX groups (44.4% vs. 56.6%, p = 0.516), with no significant association in Cox analysis (adjusted HR: 0.790; 95% CI: 0.404–1.543; p = 0.49) or IPTW (weighted HR: 0.85; 95% CI: 0.446–1.617; p = 0.62).
Conclusion
PMX‐HA was significantly associated with a lower risk of 1‐year mortality in patients with IAI, but not in those with EAI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Critical and Intensive Care Medicine, Shiga University of Medical Science, Otsu, Japan.
- Shiga University of Medical Science Emergency and Intensive Care Unit, Otsu, Japan.
ORCID-Profile: Tomoki Tanaka
Zitieren
APA
Tanaka, T., Fujino, K., Tsujita, Y., Matsumoto, Y., Fujino, M., Miyatake, H., Mizumura, N., Shimizu, J., Kishimoto, T., & Shiomi, N. (2025). Differential Impact of Polymyxin B Hemadsorption on Long‐Term Mortality in Septic Shock: A Retrospective Analysis of Intra‐Abdominal Versus Extra‐Abdominal Infections. Artificial Organs. https://doi.org/10.1111/aor.70023
Vancouver
Tanaka T, Fujino K, Tsujita Y, Matsumoto Y, Fujino M, Miyatake H, et al. Differential Impact of Polymyxin B Hemadsorption on Long‐Term Mortality in Septic Shock: A Retrospective Analysis of Intra‐Abdominal Versus Extra‐Abdominal Infections. Artificial Organs. 2025. doi:10.1111/aor.70023
BibTeX
@article{Tanaka2025,
author = {Tanaka, Tomoki and Fujino, Kazunori and Tsujita, Yasuyuki and Matsumoto, Yugo and Fujino, Mitsuhiro and Miyatake, Hidemitsu and Mizumura, Naoto and Shimizu, Junji and Kishimoto, Takuma and Shiomi, Naoto},
title = {Differential Impact of Polymyxin B Hemadsorption on Long‐Term Mortality in Septic Shock: A Retrospective Analysis of Intra‐Abdominal Versus Extra‐Abdominal Infections},
journal = {Artificial Organs},
year = {2025},
doi = {10.1111/aor.70023}
}
EUVIMED